Parnell Pharma Balance Sheet - Quarterly (OTCMKTS:PARNF)

Add to My Stocks
$0.3 $0.01 (3.23%) PARNF stock closing price Mar 20, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Parnell Pharma stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Parnell Pharma stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Parnell Pharma revenue Parnell Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Parnell Pharma balance sheet for 2016 Q4 shows cash on hand of $5.29M. The company has a debt to equity ratio of .

View and download Parnell Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jan - Dec2016 Q42016 Q32015 Q4
Marketable Securities---
Raw Materials---
Work In Progress---
Finished Goods1.86M-1.67M
Notes Receivable---
Other Current Assets---
Total Current Assets
Property Plant & Equipment13.35M-13.1M
Accumulated Depreciation4.33M-3.56M
Net Property Plant & Equipment
Investment & Advances---
Other Non-Current Assets---
Deferred Charges---
Deposits & Other Assets---
Total Assets
Notes Payable---
Accounts Payable5.85M6.06M5.1M
Current Portion Long-Term Debt-5.3M2.35M
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities---
Total Current Liabilities
Deferred Taxes/Income---
Convertible Debt---
Long-Term Debt22.18M7.53M10.8M
Non-Current Capital Leases---
Other Long-Term Liabilities---
Total Liabilities
Minority Interest---
Preferred Stock---
Common Stock Net47.24M47.98M41.65M
Capital Surplus---
Retained Earnings-41.1M-39.54M-25.27M
Treasury Stock---
Other Liabilities-0.13M--1.13M
Shareholders Equity5.99M9.22M15.24M
Total Liabilities & Shareholders Equity35.38M29.6M34.78M
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at Parnell Pharma historical stock prices and the current Parnell Pharma stock price can tell you how the stock price has moved, whereas the Parnell Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Parnell Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Parnell Pharma had total assets of $35.38M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Parnell Pharma is $29.38M. Shareholders equity comes under liabilities as it is money the company owes the holders of PARNF stock.

Parnell Pharma Balance Sheet - Key Ratios

Quarterly Balance Sheets For Parnell Pharmaceuticals Holdings Ltd Peers

Amerisourcebergen balance sheet, Acura Pharma balance sheet, GlobeImmune balance sheet, Sunwin Stevia balance sheet